Catalyst Wire Dossier Catalyst Wire Dossier

insulin glargine 300 U/mL

insulin glargine · Sanofi
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for insulin glargine 300 U/mL, covering 2022-04-25 to 2022-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin [Phase 4]

See pricing